Janelle Waite

5PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Data structures and algorithmsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2026
DNA hypomethylating agents preserve T cell stemness and potentiate the efficacy of CD3-bispecific antibodies.

|May 20, 2024
Designing meaningful continuous representations of T cell receptor sequences with deep generative models.

Allen Y Leary, Darius Scott, Namita T Gupta

|Jun 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.

Janelle C Waite, Bei Wang, Lauric Haber

|Jan 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.

Dimitris Skokos, Janelle C Waite, Lauric Haber

|Nov 04, 2018
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8.

Bei Wang, Wen Zhang, Vladimir Jankovic

Pageof 1

Frequent Collaborators

4 joint publications

Dimitris Skokos

3 joint publications

Jacquelynn Golubov

3 joint publications

Andrew J Murphy

3 joint publications

Bei Wang